Seborrhea Global Clinical Trials Review, H2, 2012

GlobalData''s clinical trial report, “Seborrhea Global Clinical Trials Review, H2, 2012" provides data on the Seborrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seborrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Seborrhea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData''s team of industry experts.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies 

Get your copy of this report @  http://www.reportsnreports.com/reports/185534-seborrhea-global-clinical-trials-review-h2-2012.html 

Report Details:
Published: August 2012
No. of Pages: 74 
Price: Single User License:US$ 2500 Corporate User License:US$7500 

   

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Seborrhea 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Seborrhea 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Seborrhea Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Astion Pharma A/S 29
Clinical Trial Overview of Astion Pharma A/S 29
Stiefel Laboratories, Inc. 30
Clinical Trial Overview of Stiefel Laboratories, Inc. 30
Pierre Fabre Dermatologie 31
Clinical Trial Overview of Pierre Fabre Dermatologie 31
Laboratoire Labcatal 32
Clinical Trial Overview of Laboratoire Labcatal 32
Aria Aesthetics, Inc. 33
Clinical Trial Overview of Aria Aesthetics, Inc. 33
Dermal Laboratories Limited 34
Clinical Trial Overview of Dermal Laboratories Limited 34
Dermatology Research Center Inc. 35
Clinical Trial Overview of Dermatology Research Center Inc. 35
Montana Pain Management, Inc. 36
Clinical Trial Overview of Montana Pain Management, Inc. 36
Mantecorp Industria Quimica e Farmaceutica Ltda 37
Clinical Trial Overview of Mantecorp Industria Quimica e Farmaceutica Ltda 37
Mimetica Pty Ltd. 38
Clinical Trial Overview of Mimetica Pty Ltd. 38
Maruho Co.,Ltd. 39
Clinical Trial Overview of Maruho Co.,Ltd. 39
Moberg Derma AB 40
Clinical Trial Overview of Moberg Derma AB 40
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
IDEA AG 42
Clinical Trial Overview of IDEA AG 42
Glenmark Pharmaceuticals Ltd. 43
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 43
Galderma S.A. 44
Clinical Trial Overview of Galderma S.A. 44
Clinical Trial Overview of Top Universities / Institutes / Hospitals 45
Milton S. Hershey Medical Center 45
Clinical Trial Overview of Milton S. Hershey Medical Center 45
University of Kiel 46
Clinical Trial Overview of University of Kiel 46
Tehran University of Medical Sciences 47
Clinical Trial Overview of Tehran University of Medical Sciences 47
Pusan National Unversity Hospital 48
Clinical Trial Overview of Pusan National Unversity Hospital 48
Federal University of Sao Paulo 49
Clinical Trial Overview of Federal University of Sao Paulo 49
Ascension Health 50
Clinical Trial Overview of Ascension Health 50
Five Key Clinical Profiles 51
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 74

Complete 2012 Induced Pluripotent Stem Cell Industry Report

Stem cell research and experimentation has been in process for well over five decades. Stem cells have the unique characteristics whereby they are able to divide and replicate repeatedly in addition to their being “unspecialized” with the ability to differentiate into specialized cell types. The possibilities that arise with the perfecting of cell replication has caused this area of exploration to remain on the forefront of scientific research, with ongoing hope that cures and treatment of diseases as well as reparative cell therapy, tissue regeneration and pharmacological testing on cell-specific tissue will one day become viable options within the medical community. Diseases such as Huntington’s Chorea, Parkinson’s Disease, and spinal cord injuries are just some examples of potential clinical applications where stem cells can offer potential benefits in halting or even reversing medical conditions that previously had no positive outcome potential – and induced pluripotent stem cells represent a preferred cell type for this type of disease reversal research.

Traditionally, scientists have worked with both embryonic and adult stem cells. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding the use of embryonic cells for research. Although adult stem cells can differentiate slightly, they are typically limited to differentiation within their original tissue type, creating narrow options for their use.

Get your copy of this report @  http://www.reportsnreports.com/reports/180517-complete-2012-induced-pluripotent-stem-cell-industry-report.html 

Report Details:
Published: August 2012
No. of Pages: 157
Price: Single User License:US$ 3495 Corporate User License:US$4000 

  

Discovery
Groundbreaking experimentation in 2006 led to the introduction of “induced pluripotent stem cells” (iPSC). These are adult cells which are isolated and then transformed into embryotic-like stem cells through the manipulation of gene expression as well as other methods. Research and experimentation using mouse cells at Kyoto University in Japan was the first instance where there was successful generation of the iPSC. In 2007, a series of follow-up experiments were done at Kyoto University in Japan where human adult cells were transformed into iPSC cells.

While there is excitement at the prospect of what such artificially remanufactured cells can contribute to medical advances, there have been issues along the way which have proven to be prohibitive. By 2010, there were a number of private industries ready to capitalize on this breakthrough technology. One such company, Advanced Cell Technology in Worcester, Massachusetts, discovered some problematic issues as they conducted experiments prior to applying for U.S. Food and Drug Administration approval to utilize iPSC in therapeutic capacities. Concerns such as premature cell death, mutation into cancer cells and low proliferation rates were some of the problems that surfaced.

Research Advances
Continued research and experimentation has resulted in numerous advances and triumphs over the last few years. According to “Circulation Research” (2012), the University of Michigan developed innovative methods to use bioengineered stem cells derived from skin biopsies to create cardiac muscle cells. This accomplishment has allowed advanced research to take place in treating medical therapies and drug treatments in diseased heart muscle.

Advances will continue to be perfected in the areas of reprogramming adult cells in appropriate conditions that will result in minimal negative outcomes. Original techniques, such as viral induced transcription processes, are being replaced with newer technology as private industries join with the scientific community to develop safe and efficient methods. With sustained research and experimentation, established guidelines related to safety and efficacy can be developed. Induced pluripotent stem cells are a promising therapy for many previously incurable medical diseases.

Market Metrics - iPSC Research Products
For this reason a large and thriving research products market has grown into existence for this cell type. Induced pluripotent stem cells (iPSC) are now sold by 53.4% of U.S. research product companies, and 38.7% of research product companies worldwide. Annual growth in the number of iPSC research product sold worldwide has been growing at a rate of 14.7% per year for the past five years. In addition, 31% of all stem cell researchers identify as having using iPSC for a research project. It is clear that iPSC are a vital research trend within the scientific community. Therapeutic applications of iPSC are considered, but within the context of the research product opportunities these trends represent.

Perhaps the most distinctive feature of this report are the breakthrough findings discovered as a result of surveying 293 researchers that identify as having induced pluripotent stem cells as their core research focus. Of the 293 respondents, 181 were U.S. based and 112 were international. These key survey findings reveal iPSC researcher wants and needs, technical preferences, and key factors influencing buying decisions. These vital findings can be used to direct the product development and product positioning decisions. Remember, to benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.

Key Findings Include

• Charts, Timelines, Metrics and Financials for the iPSC Research Product Market
• Trends for iPSC Grants, Publications, Patents, and More
• 5-Year Market Projection Data for 2012-2017
• Competitive Environment Analysis, Including Market Share by Competitor
• Preferred Species for iPSC Research
• iPSC Product Categories (Breakdown of Market Share by Each)
• Consumer Behavioral Patterns and Preferred Providers
• Crucial Trends and Unmet Market Needs
• “Tested Sentences” for Selling to iPSC Scientists
• Trends in Marketing, Including a Breakdown of the Marketing Methods Used by Your Competition - Google Ads, Facebook Ads, App Advertising, Purchased Email Lists, Website Advertisements, Trade Journals, and More.
• End-User Wants/Needs, Technical Preferences, and Factors Influencing Purchasing Decisions (Survey of iPSC Researchers)

In summary, this is a must-read industry report for research supply companies to optimally position themselves to sell iPSC research products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the market place, and take advantage crucial iPSC trends. Claim this report now to profit from this expanding market- or your competition will.

Global LNG Market to 2020 - Emerging Suppliers, Changing Trade Dynamics and New Technologies to Usher in a Paradigm Shift

“Global LNG Market to 2020 - Emerging Suppliers, Changing Trade Dynamics and New Technologies to Usher in a Paradigm Shift”, is the latest report from GlobalData, the industry analysis specialist, which analyzes the global Liquefied Natural Gas (LNG) market. The report provides an overview of the global LNG market, its key emerging suppliers, the changing trade dynamics and new technologies that have entered the market. The report also provides details of the key drivers and issues in the global LNG market. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

This report discusses the global LNG market, its key trends and issues, the key emerging suppliers, and the changing trade dynamics and new technologies in the market. The report primarily focuses on the following - 
- An overview of the global LNG market to 2020
- The trends and issues in the global LNG market
- Analysis of emerging suppliers in the global LNG market 
- The changing trade dynamics in the global LNG market
- The impact of new technologies on the global LNG market

Reasons to buy
This report will enhance your decision-making capabilities. It will allow you to - 
- Gain insight on the global LNG market
- Learn about global LNG demand and supply to 2020
- Know the liquefaction and regasification capacities of the top six countries in the world during the 2012-2020 period
- Learn about the key trends and issues in the global LNG market
- Understand the key emerging suppliers in the global LNG market
- Analyze the changing trade dynamics of the global LNG market
- Understand the new technologies available in the global LNG market 

Buy your copy of this report @ http://www.reportsnreports.com/reports/185508-global-lng-market-to-2020-emerging-suppliers-changing-trade-dynamics-and-new-technologies-to-usher-in-a-paradigm-shift.html 

Report Details:
Published: August 2012
No. of Pages: 59 
Price: Single User License:US$ 3995 Corporate User License:US$11985

   

1 Table of Contents 3
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Overview 6
2.2 GlobalData Report Guidance 6
3 Global LNG Market - Overview 7
3.1 The Global LNG Supply is Expected to Outstrip Demand by 2020 8
3.2 Australia is Likely to Overtake Qatar as the Country with Largest LNG Liquefaction Capacity in the World by 2016 9
3.3 Japan will Continue to be the Leading Country in Terms of LNG Regasification Capacity in 2016 13
4 Global LNG Market - Trends and Issues 17
4.1 Asia-Pacific will Witness the Highest Regasification Capacity Additions in the World 17
4.2 East Africa has the Potential to Emerge as New Frontier for Exports of LNG to the World 18
4.3 China is Expected to Become Second Largest Importer of LNG in the World by 2020 19
4.4 New Maritime Regulations will Create New Market worth $2 Billion for LNG Producers 20
4.5 Global LNG Market is Likely to Face Supply Constraints in Next Few Years due to Japan’s High LNG Demand 21
4.6 Low Natural Gas Demand and Government Austerity Measures have Postponed the El Musel LNG Import Terminal in Spain 22
4.7 International Sanctions have Derailed Iran’s LNG Export Plans 23
5 Emerging Suppliers in the Global LNG Market 24
5.1 Australia Plans to be one of the Top Two Exporters of LNG in the World by 2020 25
5.2 Canada has the Potential to Become a Major Supplier in the Global LNG Market 26
5.2.1 Kitimat LNG Terminal in Canada is Expected to Start LNG Exports from 2015 26
5.2.2 Petronas and Progress Energy are Planning a Feasibility Study for an LNG Export Facility on the West Coast of British Columbia 28
5.3 Commercial Production of Shale Gas in the US has Created Opportunities for LNG Exports 29
5.3.1 Federal Energy Regulatory Commission Approved Sabine Pass Terminal for Exports of LNG in April 2012 29
5.3.2 Several Consumer, Manufacturing and Environmental Groups are Opposing LNG Exports from the US 31
5.3.3 The Impact of US LNG Exports on Domestic Natural Gas Prices could be Moderate 32
5.3.4 LNG Exports will Boost the US Natural Gas Exploration and Production Industry and Bring Foreign Exchange 33
5.4 Papua New Guinea is the New Emerging LNG Supplier from Asia-Pacific 35
5.4.1 Papua New Guinea is Expected to Witness Start of Four New LNG Export Projects by 2014 36
5.5 Mozambique Could Emerge as a Major LNG Exporter in the World by 2020 38
5.5.1 Anadarko Petroleum and Eni Made a Significant Natural Gas Discovery in Offshore Mozambique 38
6 Changing Trade Dynamics in the Global LNG Market 42
6.1 Japan and South Korea Plan to Form “Buyer Consortium” for Greater Bargaining Power 42
6.2 Natural Gas Prices Could be Delinked from Crude Oil Prices due to Increasing Global LNG Trade and the Start of US LNG Exports 44
6.3 The Increase in the Number of LNG Importing Countries will accelerate the Growth of Global LNG Demand by 2020 45
6.4 Floating LNG Terminals will Play a Significant Role in the Global LNG Trade 46
6.4.1 FLNG Regasification Terminals to Account for 27.4% of Global Regasification Capacity Addition by 2016 47
6.5 Increasing Project Costs and Tightened Regulations in Australia Could Significantly Impact the Growth of Global Liquefaction Capacity by 2020 48
7 New Technologies will Play a Significant Role in the Expansion of Global LNG Trade 49
7.1 Floating LNG Production Terminals will Help in the Monetization of Challenging Offshore Natural Gas Reserves 49
7.1.1 Shell Plans to Build the World’s First Floating Liquefied Natural Gas (FLNG) Production Facility Offshore Australia 50
7.2 Offshore LNG Regasification Terminals have Emerged as a Cost-effective Alternative to Land-based Terminals 51
7.2.1 Floating Storage and Regasification Unit (FSRU) Technology Substantially Lowered the Lead Times for Development of LNG Import Infrastructure 51
7.2.2 Shuttle Regasification Vehicles Regasify LNG while on the Move 52
7.2.3 Gravity Based Structures Enable Permanent Offshore Regasification of LNG on Fixed Platform 53
7.3 Development of Small to Mid-scale Natural Gas Liquefaction Technology has the Potential to Address Regional Energy Necessities 54
7.4 Mitsubishi Heavy Industries Completed Development of New Generation LNG Carrier, EXTREM 55
8 Appendix 56
8.1 Market Definition 56
8.2 Abbreviations 56
8.3 Sources 57
8.4 Methodology 58
8.4.1 Coverage 58
8.4.2 Secondary Research 58
8.4.3 Primary Research 59
8.4.4 Expert Panel Validation 59
8.5 Contact Us 59
8.6 Disclaimer 59

Planned Oil and Gas Pipelines - Global Market Analysis, Competitive Landscape and Major Projects to 2016

“Planned Oil and Gas Pipelines - Global Market Analysis, Competitive Landscape and Major Projects to 2016”, is the latest report from GlobalData, the industry analysis specialist, that analyzes the global planned oil and gas pipelines market. The report provides information about the global planned pipelines market until 2016. The report gives information on planned pipeline lengths by the top five countries and the top five companies in each region. It also covers key planned pipeline projects in each region. The report also provides key trends and issues in the pipeline industry. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
This report provides a detailed analysis of the planned oil and gas pipeline markets, and the key companies, trends and issues in the industry until 2016. The report primarily focuses on - 
- The planned oil and gas pipelines market
- The top five countries and top five companies, by planned pipeline length, for each region
- The key planned pipeline projects in each region
- The key issues and trends in pipeline sector
- The competitive landscape of the planned pipeline sector, and a comparison between the key companies and planned pipeline projects

Reasons to buy

The report will enhance your decision-making capabilities. It will allow you to - 
- Keep abreast of various planned oil and gas pipeline projects across the world.
- Develop business strategies with the help of specific insights about the planned pipeline markets.
- Identify issues and trends in the planned pipeline markets.
- Analyze and make comparisons between different companies present in the pipeline markets. 

Buy your copy of this report @ http://www.reportsnreports.com/reports/185507-planned-oil-and-gas-pipelines-global-market-analysis-competitive-landscape-and-major-projects-to-2016.html 

Report Details:
Published: August 2012
No. of Pages: 74 
Price: Single User License:US$ 3995 Corporate User License:US$11985 

   

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 7
2.1 Overview 7
2.2 GlobalData Report Guidance 7
3 Global Planned Oil and Gas Pipeline Market 8
3.1 Global Planned Oil and Gas Pipeline Market, Overview 8
3.1.1 Global Planned Oil and Gas Pipeline Market, Regional Analysis by Pipeline Length, 2012–2016 9
3.1.2 Global Planned Oil and Gas Pipeline Market, Pipeline Length by Commodity, 2012–2016 10
3.1.3 Global Planned Oil and Gas Pipeline Market, Key Planned Pipeline, 2012–2016 11
3.2 Global Planned Oil and Gas Pipelines, Market Share Analysis 12
3.2.1 Global Planned Oil and Gas Pipeline Market, Top Five Countries by Pipeline Length, 2012–2016 12
3.2.2 Global Planned Oil and Gas Pipeline Market, Top Five Companies by Pipeline Length, 2012–2016 13
4 Global Planned Oil and Gas Pipeline Market, Key Trends and Issues 14
4.1 Global Planned Oil and Gas Pipeline Market, Key Trends 14
4.1.1 Increasing Oil and Gas Consumption and Growing Demand in Asia-Pacific will Promote Pipeline Construction 14
4.1.2 Increase Production from Unconventional Oil and Gas Sources are Instrumental in Boosting Pipeline Constructions in North America 14
4.2 Global Planned Oil and Gas Pipeline Market, Key Issues 15
4.2.1 Geopolitical Issues May Hamper Development of Planned Pipelines 15
5 Asia-Pacific Planned Oil and Gas Pipeline Market 16
5.1 Asia-Pacific Planned Oil and Gas Pipeline Market, Overview 16
5.1.1 Asia-Pacific Planned Oil and Gas Pipeline Market, Pipeline Length by Commodity, 2012–2016 17
5.2 Asia-Pacific Planned Oil and Gas Pipelines, Market Share Analysis 18
5.2.1 Asia-Pacific Planned Oil and Gas Pipeline Market, Top Five Countries by Pipeline Length, 2012–2016 18
5.2.2 Asia-Pacific Planned Oil and Gas Pipeline Market, Top Five Companies by Pipeline Length, 2012–2016 20
5.3 Asia-Pacific Planned Oil and Gas Pipelines, Key Oil and Gas Pipelines 21
5.3.1 Asia-Pacific Planned Oil and Gas Pipeline Market, Key Crude Oil Pipelines by Pipeline Length, 2012–2016 21
5.3.2 Asia-Pacific Planned Oil and Gas Pipeline Market, Key Petroleum Product Pipelines by Pipeline Length, 2012–2016 23
5.3.3 Asia-Pacific Planned Oil and Gas Pipeline Market, Key Natural Gas Pipelines by Pipeline Length, 2012–2016 25
6 Europe Planned Oil and Gas Pipeline Market 28
6.1 Europe Planned Oil and Gas Pipeline Market, Overview 28
6.1.1 Europe Planned Oil and Gas Pipeline Market, Pipeline Length by Commodity, 2012–2016 29
6.2 Europe Planned Oil and Gas Pipelines, Market Share Analysis 30
6.2.1 Europe Planned Oil and Gas Pipeline Market, Top Five Countries by Pipeline Length, 2012–2016 30
6.2.2 Europe Planned Oil and Gas Pipeline Market, Top Five Companies by Pipeline Length, 2012–2016 31
6.3 Europe Planned Oil and Gas Pipelines, Key Oil and Gas Pipelines 32
6.3.1 Europe Planned Oil and Gas Pipeline Market, Key Crude Oil Pipelines by Pipeline Length, 2012–2016 32
6.3.2 Europe Planned Oil and Gas Pipeline Market, Key Natural Gas Pipelines by Pipeline Length, 2012–2016 35
6.3.3 Europe Planned Oil and Gas Pipeline Market, Key Petroleum Product Pipelines by Pipeline Length, 2012–2016 37
7 Middle East and Africa Planned Oil and Gas Pipeline Market 38
7.1 Middle East and Africa Planned Oil and Gas Pipeline Market, Overview 38
7.1.1 Middle East and Africa Planned Oil and Gas Pipeline Market, Pipeline Length by Commodity, 2012–2016 39
7.2 Middle East and Africa Planned Oil and Gas Pipelines, Market Share Analysis 40
7.2.1 Middle East and Africa Planned Oil and Gas Pipeline Market, Top Five Countries by Pipeline Length, 2012–2016 40
7.3 Middle East and Africa Planned Oil and Gas Pipelines, Key Oil and Gas Pipelines 41
7.3.1 Middle East and Africa Planned Oil and Gas Pipeline Market, Key Crude Oil Pipelines by Pipeline Length, 2012–2016 41
7.3.2 Middle East and Africa Planned Oil and Gas Pipeline Market, Key Petroleum Product Pipelines by Pipeline Length, 2012–2016 44
7.3.3 Middle East and Africa Planned Oil and Gas Pipeline Market, Key Natural Gas Pipelines by Pipeline Length, 2012–2016 46
8 North America Planned Oil and Gas Pipeline Market 47
8.1 North America Planned Oil and Gas Pipeline Market, Overview 47
8.1.1 North America Planned Oil and Gas Pipeline Market, Pipeline Length by Commodity, 2012–2016 48
8.2 North America Planned Oil and Gas Pipelines, Market Share Analysis 49
8.2.1 North America Planned Oil and Gas Pipeline Market, Key Countries by Pipeline Length, 2012–2016 49
8.2.2 North America Planned Oil and Gas Pipeline Market, Key Companies by Pipeline Length, 2012–2016 50
8.3 North America Planned Oil and Gas Pipelines, Key Oil and Gas Pipelines 51
8.3.1 North America Planned Oil and Gas Pipeline Market, Key Crude Oil Pipelines by Pipeline Length, 2012–2016 51
8.3.2 North America Planned Oil and Gas Pipeline Market, Key Petroleum Product Pipelines by Pipeline Length, 2012–2016 53
8.3.3 North America Planned Oil and Gas Pipeline Market, Key Natural Gas Pipelines by Pipeline Length, 2012–2016 56
9 South and Central America Planned Oil and Gas Pipeline Market 57
9.1 South and Central America Planned Oil and Gas Pipeline Market, Overview 57
9.1.1 South and Central America Planned Oil and Gas Pipeline Market, Pipeline Length by Commodity, 2012–2016 58
9.2 South and Central America Planned Oil and Gas Pipelines, Market Share Analysis 59
9.2.1 South and Central America Planned Oil and Gas Pipeline Market, Top Five Countries by Pipeline Length, 2012–2016 59
9.2.2 South and Central America Planned Oil and Gas Pipeline Market, Key Companies by Pipeline Length, 2012–2016 61
9.3 South and Central America Planned Oil and Gas Pipelines, Key Oil and Gas Pipelines 62
9.3.1 South and Central America Planned Oil and Gas Pipeline Market, Key Crude Oil Pipelines by Pipeline Length, 2012–2016 62
9.3.2 South and Central America Planned Oil and Gas Pipeline Market, Key Petroleum Product Pipelines by Pipeline Length, 2012–2016 64
9.3.3 South and Central America Planned Oil and Gas Pipeline Market, Key Natural Gas Pipelines by Pipeline Length, 2012–2016 65
10 Competitive Landscape 67
10.1 Global Planned Oil and Gas Pipeline Market, Comparison of Key Pipeline Projects 67
10.2 Global Planned Oil and Gas Pipeline Market, Comparison of the Key Pipeline Companies 68
10.2.1 GAIL Aims to Build Gas Transmission Network within India 69
10.2.2 CNPC’s Planned Pipelines will Help China to Secure Oil and Natural Gas Supplies from Myanmar and Kazakhstan 69
10.2.3 Gazprom’s Aims to Bypass Traditional Transit Countries through its Planned Pipelines 70
10.2.4 TransCanada through Planned Keystone XL Pipeline Plans to Supply Oil from Canada’s Oil Sands Region to the US Gulf Coast 70
10.2.5 Planned Pipelines will Allow Transneft to Expand its Oil Export Markets 70
11 Appendix 71
11.1 Market Definition 71
11.2 Abbreviations 71
11.3 Sources 72
11.4 Methodology 72
11.4.1 Coverage 73
11.4.2 Secondary Research 73
11.4.3 Primary Research 73
11.4.4 Expert Panel Validation 74
11.5 Contact Us 74
11.6 Disclaimer 74